Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,390 | -7,046 | -3,022 | -11,204 | -10,179 |
| Depreciation Amortization | 710 | 478 | 239 | 955 | 701 |
| Accounts receivable | 413 | 597 | 676 | -727 | 25 |
| Other Working Capital | -479 | 560 | 111 | -641 | -157 |
| Other Operating Activity | 153 | 3 | -382 | 103 | -891 |
| Operating Cash Flow | $-8,593 | $-5,407 | $-2,378 | $-11,514 | $-10,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -6,603 |
| PPE Investments | -114 | -66 | -21 | -142 | -105 |
| Purchase Of Investment | -4,500 | -4,500 | -4,500 | -18,603 | N/A |
| Sale Of Investment | 8,000 | 8,000 | 5,000 | 16,400 | N/A |
| Purchase Sale Intangibles | -366 | -191 | -88 | -504 | -409 |
| Other Investing Activity | -366 | -191 | -87 | -504 | -409 |
| Investing Cash Flow | $3,020 | $3,243 | $392 | $-2,849 | $-7,117 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,800 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1 | N/A | N/A | 16,290 | 16,290 |
| Dividend Paid | N/A | N/A | N/A | -23 | -23 |
| Other Financing Activity | -39 | 0 | 0 | 36 | 36 |
| Financing Cash Flow | $1,762 | $N/A | $N/A | $16,303 | $16,303 |
| Exchange Rate Effect | -28 | 20 | 17 | -11 | 81 |
| Beginning Cash Position | 10,251 | 10,251 | 10,251 | 8,322 | 8,322 |
| End Cash Position | 6,412 | 8,107 | 8,282 | 10,251 | 7,087 |
| Net Cash Flow | $-3,839 | $-2,144 | $-1,969 | $1,929 | $-1,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,593 | -5,407 | -2,378 | -11,514 | -10,501 |
| Capital Expenditure | -114 | -66 | -21 | -142 | -105 |
| Free Cash Flow | -8,707 | -5,474 | -2,398 | -11,655 | -10,606 |